Sponsors (7)
Introduced February 6, 2025 by Melanie Ann Stansbury · Last progress February 6, 2025
The bill substantially increases authorities to track, register, and disrupt diversion of pill‑making equipment—likely reducing illicit pill production and overdose risk—but does so by imposing significant compliance costs, privacy/data‑security risks, and regulatory uncertainty on legitimate manufacturers, dealers, and supply‑chain actors.
Law enforcement and communities: a new national registration/serial-number/reporting regime across manufacturers, dealers, importers, and exporters makes it much easier to trace and disrupt diversion of tableting/encapsulating machines and critical parts, reducing illicit pill production and likely lowering overdose risk.
Suppliers, distributors, and dealers: mandatory reporting of suspicious transactions and clearer recordkeeping obligations improve early detection of attempts to divert components into illegal fentanyl or pill manufacturing.
Lawful manufacturers and distributors: explicit coverage of machines and parts plus registration/records requirements create clearer legal obligations and pathways to demonstrate compliance, which can reduce wrongful suspicion and help legitimate businesses operate within the law.
Manufacturers, distributors, importers, exporters, dealers and other small businesses: the bill imposes broad new registration, annual fees/inspections, serial-numbering, reporting, and recordkeeping requirements that create substantial compliance costs and administrative burdens.
Legitimate medical, pharmaceutical, and trade actors: added export/import controls, registration suspensions or revocations, and transaction delays could disrupt supply chains and international commerce, increasing costs and interrupting business operations.
Manufacturers, dealers, and taxpayers: centralized registries and expanded reporting heighten privacy, commercial-confidentiality, and data-security risks if supply-chain or ownership information is mishandled or exposed.
Based on analysis of 7 sections of legislative text.
Requires serial IDs, mandatory registration, reporting, and a national registry for pill-tableting and encapsulating machines and key parts; makes tampering and unregistered dealing criminal offenses.
Requires permanent serial identification, registration, reporting, and recordkeeping for tableting machines, encapsulating machines, and specified "critical parts," and creates a national Pill Press Registry maintained by the Attorney General. It expands existing controlled-substance definitions and reporting duties, makes dealing in unregistered machines or parts unlawful, and creates new criminal prohibitions against removing or altering serial numbers and possessing or transporting machines or parts without required serials, with limited exemptions and phased effective dates. Imposes new compliance duties on manufacturers, distributors, importers, exporters, dealers, and other persons who handle these machines or parts, grants the Attorney General broad rulemaking and inspection authority, and establishes timelines and affirmative defenses for certain pre-existing possession or remedial acts.